Covered recipient · General Payments record
JUSTINA TSENG
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2024
$2,627.61
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $690.48 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $176.26 | 4 |
| ABBVIE INC. | $147.33 | 7 |
| Amgen Inc. | $95.07 | 5 |
| PFIZER INC. | $91.91 | 5 |
| SOBI, INC | $52.73 | 2 |
| Organon LLC | $47.77 | 2 |
| E.R. Squibb & Sons, L.L.C. | $24.17 | 1 |
| UCB, Inc. | $21.12 | 1 |
| Kiniksa Pharmaceuticals International, plc | $19.51 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.14 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106249531 | CMS |
| ABBVIE INC. | $22.61 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106249533 | CMS |
| ABBVIE INC. | $19.60 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106249535 | CMS |
| ABBVIE INC. | $25.30 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106249537 | CMS |
| ABBVIE INC. | $22.42 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106249539 | CMS |
| ABBVIE INC. | $20.66 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106249541 | CMS |
| ABBVIE INC. | $22.60 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106249543 | CMS |
| Amgen Inc. | $19.69 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111728515 | CMS |
| Amgen Inc. | $25.78 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111728519 | CMS |
| Amgen Inc. | $16.11 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111728521 | CMS |
| Amgen Inc. | $16.42 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111728517 | CMS |
| Amgen Inc. | $17.07 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402592 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.71 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105327673 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.71 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105504680 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.74 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104347018 | CMS |
| AstraZeneca Pharmaceuticals LP | $10.10 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105783282 | CMS |
| E.R. Squibb & Sons, L.L.C. | $24.17 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101433625 | CMS |
| Kiniksa Pharmaceuticals International, plc | $19.51 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154855601 | CMS |
| Novartis Pharmaceuticals Corporation | $14.61 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087403732 | CMS |
| Organon Llc | $29.81 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136215260 | CMS |
| Organon Llc | $17.96 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136215264 | CMS |
| PFIZER INC. | $17.45 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130905550 | CMS |
| PFIZER INC. | $20.83 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130930310 | CMS |
| PFIZER INC. | $19.40 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130959563 | CMS |
| PFIZER INC. | $16.97 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130987481 | CMS |
| PFIZER INC. | $17.26 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131063113 | CMS |
| SOBI, INC | $29.61 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141424013 | CMS |
| SOBI, INC | $23.12 | 09/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141409992 | CMS |
| UCB, Inc. | $21.12 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143265263 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.